PLAY PODCASTS
Myelodysplastic Syndromes (MDS): Caring for Low and High-Risk Patients

Myelodysplastic Syndromes (MDS): Caring for Low and High-Risk Patients

Treating Blood Cancers

July 22, 202037m 25s

Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

James M. Foran, MD, FRCPC, Mayo Clinic Cancer Center, Jacksonville, FL

Recorded on May 28, 2020


Listen in as Dr. James Foran from Mayo Clinic defines MDS, discusses the diagnostic workup and factors used to develop a treatment plan, including the importance of the morphology of the bone marrow and the blast count, cytogenetics and next generation sequencing and patient management strategies for low and high-risk MDS. The conversation continues with potentially exciting treatment options being studied in clinical trials, the impact of COVID-19 on caring for patients with MDS, and the involvement of the entire healthcare team.
James M. Foran, MD, FRCPC
James M. Foran, MD, FRCPC
Consultant & Associate Professor
Division of Hematology & Medical Oncology
Mayo Clinic Cancer Center
Jacksonville, FL